TrialBMC cancer2023

Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).

Tomoya Yokota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.